-
DiscoveryIntractable tumor cells crippled
Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.
Discovery -
DiscoveryLeveraging the liver’s ability to heal scarred tissue
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
Discovery -
From Our LabsOpening chemistry education to the world
Novartis taps MOOC technology to share chemistry education with the world
From Our Labs -
DiscoveryNeuroscientists restore cell-to-cell signaling and sociability in autism models
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
Discovery -
DiscoveryNovartis and Pfizer join forces to upend oncology dogma
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
Discovery -
DiscoveryRare speed on a rare disease
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
Discovery -
From Our LabsHow to address the culture gap between academia and industry in biomedicine
Experts call for significant changes to facilitate the discovery of new treatments.
From Our Labs -
Access to HealthcareBringing modern medicine to rural Vietnam
Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.
Access to Healthcare -
From Our LabsGiraffes have high blood pressure. Why don’t they drop dead?
A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
From Our Labs -
DiscoveryStepping toward regenerative medicine for diabetes
Discovery points toward treatment options beyond insulin injections
Discovery -
DiscoveryCompounds spur insulin-producing cells to replicate in the lab
Discovery -
DiscoveryClinical trials make a move toward mice
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
Discovery